The Safety, Acceptability and Efficacy of Alena
1 other identifier
interventional
102
1 country
1
Brief Summary
The present study is a randomised controlled trial that seeks to investigate the safety, acceptability and efficacy and safety of the Alena CBT programme as a treatment for social anxiety disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 4, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 18, 2022
CompletedFirst Submitted
Initial submission to the registry
April 21, 2023
CompletedFirst Posted
Study publicly available on registry
May 15, 2023
CompletedMay 15, 2023
May 1, 2023
1 month
April 21, 2023
May 4, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Questionnaires assessing negative effects from using the app and adverse health events
The Intervention group was asked "Have you experienced any negative effects from using the Alena app? This could be a physical or emotional effect that you believe you have experienced as a result of using the app and/or engaging in the app therapy." Both groups were asked: "Have you experienced any new, serious negative health effects in the past week? This includes having to see your GP for a new reason, going to hospital, or being otherwise very unwell in terms of your physical or mental health." If participants responded positively to either question, they were prompted for additional details and to rate the severity of the experience.
Week 4 (primary endpoint)
Questionnaires assessing negative effects from using the app and adverse health events
The Intervention group was asked "Have you experienced any negative effects from using the Alena app? This could be a physical or emotional effect that you believe you have experienced as a result of using the app and/or engaging in the app therapy." Both groups were asked: "Have you experienced any new, serious negative health effects in the past week? This includes having to see your GP for a new reason, going to hospital, or being otherwise very unwell in terms of your physical or mental health." If participants responded positively to either question, they were prompted for additional details and to rate the severity of the experience.
Week 6 (2-week follow-up post-intervention)
Questionnaire assessing satisfaction, helpfulness and ease of use
Participants were asked how satisfied they were with the app overall (Likert rating scale from very dissatisfied to very satisfied); how helpful they found the app (Likert ratings from very unhelpful to very helpful); how likely they would be to recommend the app (Likert ratings from very unlikely to very likely); how easy they found using the app (Likert ratings from very difficult to very easy); whether they got to the end of the weekly exercise (yes/no), and what got in the way of completing the exercises, with options provided.
Week 4 (primary endpoint)
Questionnaire assessing satisfaction, helpfulness and ease of use
Participants were asked how satisfied they were with the app overall (Likert rating scale from very dissatisfied to very satisfied); how helpful they found the app (Likert ratings from very unhelpful to very helpful); how likely they would be to recommend the app (Likert ratings from very unlikely to very likely); how easy they found using the app (Likert ratings from very difficult to very easy); whether they got to the end of the weekly exercise (yes/no), and what got in the way of completing the exercises, with options provided.
Week 6 (2-week follow-up post-intervention)
Secondary Outcomes (4)
Social phobia inventory (SPIN)
Week 4 (primary endpoint)
Social phobia inventory (SPIN)
Week 6 (2-week follow-up post-intervention)
Work and Social Adjustment Scale (WSAS)
Week 4 (primary endpoint)
Work and Social Adjustment Scale (WSAS)
Week 6 (2-week follow-up post-intervention)
Study Arms (2)
Cognitive Behavioral Therapy program
EXPERIMENTALAccess to the "Alena" CBT-based therapy programme for 4 weeks. Each of the four therapy modules gradually became available on a weekly basis until all four were available in the final intervention week. Participants were instructed to complete one module per week. Each therapy module consisted of psychoeducational content, guided psychological reflection and perspective-taking exercises, and, where appropriate, skills training exercises such as attention training, public speaking, and exposure experiments to be completed in real life.
Waitlist control
NO INTERVENTIONWaitlist control. Participants in this arm were given access to the CBT content at the end of the 4-week trial period.
Interventions
This mobile application comprised CBT-based therapy for social anxiety based on the Clark and Wells model
Eligibility Criteria
You may qualify if:
- female
- aged between 18 and 35 years old (inclusive)
- located in the UK
- fluent in English
- comfortable taking part in a study that included deception (due to the nature of the cognitive assessments)
- had an iPhone and daily access to an internet connection
- scored over 30 on the Social Phobia Inventory (SPIN; indicating at least moderate social anxiety).
You may not qualify if:
- currently undergoing any mental health therapy
- changed the usual mental health medication or dosage within the past eight weeks
- scored eight or above on the Alcohol Use Disorders Identification Test for consumption (AUDIT-C; indicating higher risk of alcohol dependence)
- scored two or above on the adapted drug questions (indicating higher risk of drug dependence)
- had previously participated in scientific studies or user research undertaken by Alena
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aya Technologies Limited
London, United Kingdom
Related Publications (3)
Connor KM, Davidson JR, Churchill LE, Sherwood A, Foa E, Weisler RH. Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. Br J Psychiatry. 2000 Apr;176:379-86. doi: 10.1192/bjp.176.4.379.
PMID: 10827888BACKGROUNDMundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002 May;180:461-4. doi: 10.1192/bjp.180.5.461.
PMID: 11983645BACKGROUNDGarvert MM, McFadyen J, Linke S, McCloud T, Meyer SS, Sobanska S, Sharp PB, Long A, Huys QJM, Ahmadi M. Safety and Efficacy of Modular Digital Psychotherapy for Social Anxiety: Randomized Controlled Trial. J Med Internet Res. 2025 Apr 10;27:e64138. doi: 10.2196/64138.
PMID: 40208666DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mandana Ahmadi, PhD
Aya Technologies Limited
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2023
First Posted
May 15, 2023
Study Start
October 31, 2022
Primary Completion
December 4, 2022
Study Completion
December 18, 2022
Last Updated
May 15, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share